ACP
AMED

Aviance Capital Partners’s Amedisys AMED Stock Holding History

Aviance Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-32,825
Closed -$565K – 212
2013
Q3 		$565K Sell
32,825
-5,703
-15% -$84.6K 0.26% 107
2013
Q2 		$447K Buy
+38,528
New +$441K 0.24% 115

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aviance Capital Partners's AMED Position: Q4 2013 in Review

Aviance Capital Partners sold out of Amedisys (AMED) in Q4 2013, closing a stake of 32,825 shares — an estimated $565K sold.

Aviance Capital Partners first reported a position in AMED in Q2 2013 and held it in 2 quarters. The position peaked at $565K in Q3 2013. 124 funds tracked by Wall St. Rank hold AMED as of Q4 2013.

  • Aviance Capital Partners reported no remaining Amedisys position as of Q4 2013 after selling out during the quarter.
  • Aviance Capital Partners sold 32,825 Amedisys shares in Q4 2013, an estimated $565K.
  • Aviance Capital Partners first reported a position in Amedisys in Q2 2013 and held it in 2 quarters.
  • Aviance Capital Partners's Amedisys position peaked at $565K in Q3 2013.
  • 124 funds tracked by Wall St. Rank held Amedisys as of Q4 2013.

Based on Aviance Capital Partners's 13F filing for Q4 2013, filed 7 Feb 2014.